0001415889-24-027597.txt : 20241125 0001415889-24-027597.hdr.sgml : 20241125 20241125083323 ACCESSION NUMBER: 0001415889-24-027597 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241121 FILED AS OF DATE: 20241125 DATE AS OF CHANGE: 20241125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tsai Philip CENTRAL INDEX KEY: 0002026600 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 241492096 MAIL ADDRESS: STREET 1: C/O IMMUNOME, INC. STREET 2: 18702 NORTH CREEK PARKWAY, SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 18702 N. CREEK PARKWAY STREET 2: SUITE 100 CITY: BOTHELL STATE: WA ZIP: 98011 4 1 form4-11252024_011120.xml X0508 4 2024-11-21 0001472012 Immunome Inc. IMNM 0002026600 Tsai Philip C/O IMMUNOME, INC. 18702 N. CREEK PARKWAY, SUITE 100 BOTHELL WA 98011 false true false false Chief Technology Officer 0 Common Stock 2024-11-21 4 P 0 21000 9.43 A 21000 D The purchase price for the reported transactions was $9.43. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, the Reporting Person will provide the full information regarding the securities purchased. /s/ Sandra Stoneman, Attorney-in-Fact 2024-11-21